Literature DB >> 7504257

Matching chemistry and shape in molecular docking.

B K Shoichet1, I D Kuntz.   

Abstract

We have added a chemical filter to the ligand placement algorithm of the molecular docking program DOCK. DOCK places ligands in receptors using local shape features. Here we label these shape features by chemical type and insist on complementary matches. We find fewer physically unrealistic complexes without reducing the number of complexes resembling the known ligand-receptor configurations. Approximately 10-fold fewer complexes are calculated and the new algorithm is correspondingly 10-fold faster than the previous shape-only matching. We tested the new algorithm's ability to reproduce three known ligand-receptor complexes: methotrexate in dihydrofolate reductase, deoxyuridine monophosphate in thymidylate synthase and pancreatic trypsin inhibitor in trypsin. The program found configurations within 1 A of the crystallographic mode, with fewer non-native solutions compared with shape-only matching. We also tested the program's ability to retrieve known inhibitors of thymidylate synthase and dihydrofolate reductase by screening molecular databases against the enzyme structures. Both algorithms retrieved many known inhibitors preferentially to other compounds in the database. The chemical matching algorithm generally ranks known inhibitors better than does matching based on shape alone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504257     DOI: 10.1093/protein/6.7.723

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  39 in total

1.  One site fits both: a model for the ternary complex of folate + NADPH in R67 dihydrofolate reductase, a D2 symmetric enzyme.

Authors:  E E Howell; U Shukla; S N Hicks; R D Smiley; L A Kuhn; M I Zavodszky
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

2.  DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases.

Authors:  T J Ewing; S Makino; A G Skillman; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  2001-05       Impact factor: 3.686

3.  Protein-protein docking with multiple residue conformations and residue substitutions.

Authors:  David M Lorber; Maria K Udo; Brian K Shoichet
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

4.  Efficient docking of peptides to proteins without prior knowledge of the binding site.

Authors:  Csaba Hetényi; David van der Spoel
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

5.  Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention.

Authors:  Anton V Cheltsov; Mika Aoyagi; Alexander Aleshin; Eric Chi-Wang Yu; Taylor Gilliland; Dayong Zhai; Andrey A Bobkov; John C Reed; Robert C Liddington; Ruben Abagyan
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

6.  Here be dragons: docking and screening in an uncharted region of chemical space.

Authors:  Ruth Brenk; John J Irwin; Brian K Shoichet
Journal:  J Biomol Screen       Date:  2005-09-16

7.  Decoys for docking.

Authors:  Alan P Graves; Ruth Brenk; Brian K Shoichet
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

8.  Chemometric analysis of ligand receptor complementarity: identifying Complementary Ligands Based on Receptor Information (CoLiBRI).

Authors:  Scott Oloff; Shuxing Zhang; Nagamani Sukumar; Curt Breneman; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2006 Mar-Apr       Impact factor: 4.956

9.  Benchmarking sets for molecular docking.

Authors:  Niu Huang; Brian K Shoichet; John J Irwin
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

10.  Functional validation of virtual screening for novel agents with general anesthetic action at ligand-gated ion channels.

Authors:  Stephanie A Heusser; Rebecca J Howard; Cecilia M Borghese; Madeline A Cullins; Torben Broemstrup; Ui S Lee; Erik Lindahl; Jens Carlsson; R Adron Harris
Journal:  Mol Pharmacol       Date:  2013-08-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.